Thursday, June 6, 2013
Publication and contact
Direct conversion of
fibroblasts to insulin-secreting cells using DNA demethylating agents
In vitro and mouse studies suggest demethylating agents
could be used to directly convert adult fibroblasts into insulin-producing
cells. Adult human skin fibroblasts were exposed first to the DNA
demethylating agent Vidaza
and then to a three-step pancreatic differentiation protocol to produce a
population containing about 35% pancreatic cells. In culture, the converted
pancreatic cells released insulin in response to glucose challenge. In mice
with chemically induced diabetes, injection of the converted pancreatic cells
into the spinal cord restored normal glucose levels and tolerance. Next steps
include developing a protocol to produce patient-specific pancreatic cells.
Inc. and Nippon
Shinyaku Co. Ltd. market the DNA
methyltransferase inhibitor Vidaza azacitidine to treat
myelodysplastic syndrome (MDS). Celgene and Pfizer also market the drug to
treat acute myelogenous leukemia (AML).
Published online June 6, 2013
Patent application filed;
available for licensing
Pennarossa, G. et al.
Proc. Natl. Acad. Sci. USA; published online
May 21, 2013;
Contact: Tiziana A.L. Brevini, University of Milan, Milan,
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]